The global DNA Gyrase Subunit B (EC 5.99.1.3) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on DNA Gyrase Subunit B (EC 5.99.1.3) volume and value at global level, regional level and company level. From a global perspective, this report represents overall DNA Gyrase Subunit B (EC 5.99.1.3) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of DNA Gyrase Subunit B (EC 5.99.1.3) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their DNA Gyrase Subunit B (EC 5.99.1.3) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abgentis Limited
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Merck & Co., Inc.
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
GYR-12
DS-2969
VXC-100
VT-12008911
Others

Segment by Application
Bacterial Infections
Clostridium Diffclie Infections
Klebsiella Pneumoniae Infections
Others